From the Shareholder Update 5 Sep 2018, ’GMedDx will continue to...

From the Shareholder Update 5 Sep 2018,

’GMedDx will continue to provide the monitoring and support services via its existing Independent Diagnostic Testing Facility (IDTF) operations, which is eligible for Medicare reimbursement in the territory. Further to the existing service offerings within IDTF, a particular focus will extend towards Chronic Care Management (CCM), a key demographic whereby patients with chronic conditions account for ~99% ofall Medicare spending and for ~84% of US national healthcare spending overall (Centres for Medicare &1Medicaid Services, 2018) . GMedDx will provide consultation services in accordance with the Medicare reimbursement approved CCM program, with a service fee of ~US$58 for a 20-minute consultation, and ~US$94 a 60-minute ‘complex management’ consultation, fully reimbursed by Medicare per patient per month.’